SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $377,843 | +5.9% | 3,117 | 0.0% | 0.02% | +5.0% |
Q2 2023 | $356,959 | -16.9% | 3,117 | 0.0% | 0.02% | -4.8% |
Q1 2023 | $429,616 | +6.4% | 3,117 | 0.0% | 0.02% | 0.0% |
Q4 2022 | $403,901 | +17.1% | 3,117 | 0.0% | 0.02% | -12.5% |
Q3 2022 | $345,000 | +47.4% | 3,117 | 0.0% | 0.02% | +60.0% |
Q2 2022 | $234,000 | -4.1% | 3,117 | 0.0% | 0.02% | +36.4% |
Q1 2022 | $244,000 | -13.2% | 3,117 | 0.0% | 0.01% | +10.0% |
Q4 2021 | $281,000 | -2.4% | 3,117 | 0.0% | 0.01% | -52.4% |
Q3 2021 | $288,000 | +19.0% | 3,117 | 0.0% | 0.02% | +31.2% |
Q2 2021 | $242,000 | +4.3% | 3,117 | 0.0% | 0.02% | 0.0% |
Q1 2021 | $232,000 | -56.3% | 3,117 | 0.0% | 0.02% | -44.8% |
Q4 2020 | $531,000 | +21.2% | 3,117 | 0.0% | 0.03% | -45.3% |
Q3 2020 | $438,000 | -12.4% | 3,117 | 0.0% | 0.05% | -37.6% |
Q2 2020 | $500,000 | +63.9% | 3,117 | 0.0% | 0.08% | +19.7% |
Q1 2020 | $305,000 | -24.1% | 3,117 | 0.0% | 0.07% | -9.0% |
Q4 2019 | $402,000 | +71.1% | 3,117 | 0.0% | 0.08% | +62.5% |
Q3 2019 | $235,000 | -50.4% | 3,117 | 0.0% | 0.05% | -52.0% |
Q2 2019 | $474,000 | +27.4% | 3,117 | 0.0% | 0.10% | +6.4% |
Q1 2019 | $372,000 | -1.6% | 3,117 | -10.0% | 0.09% | -23.6% |
Q4 2018 | $378,000 | -32.4% | 3,462 | 0.0% | 0.12% | -14.6% |
Q3 2018 | $559,000 | +22.1% | 3,462 | 0.0% | 0.14% | +9.1% |
Q2 2018 | $458,000 | -8.2% | 3,462 | -48.6% | 0.13% | +153.8% |
Q1 2018 | $499,000 | -48.0% | 6,731 | -60.9% | 0.05% | -3.7% |
Q4 2017 | $959,000 | -62.9% | 17,231 | -69.7% | 0.05% | -43.8% |
Q3 2017 | $2,583,000 | -30.8% | 56,949 | -48.6% | 0.10% | -4.0% |
Q2 2017 | $3,735,000 | -43.1% | 110,812 | -50.0% | 0.10% | -51.0% |
Q1 2017 | $6,562,000 | +12.4% | 221,691 | +4.2% | 0.20% | +15.3% |
Q4 2016 | $5,836,000 | -80.9% | 212,776 | -57.1% | 0.18% | -84.6% |
Q3 2016 | $30,486,000 | +288.9% | 496,434 | +20.8% | 1.15% | +112.8% |
Q2 2016 | $7,839,000 | -10.7% | 411,077 | -8.6% | 0.54% | +0.4% |
Q1 2016 | $8,775,000 | +83.7% | 449,526 | +263.0% | 0.54% | +100.7% |
Q4 2015 | $4,778,000 | – | 123,850 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |